ArticleCancer immunology, immunotherapy : CII2022

Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.

Tamara Mateu-Albero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.